AGC Biologics to Manufacture Teikoku’s rhMMP-7
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
HUNTSVILLE, Ala. and KASSEL, Germany, May 20, 2026 Discovery Life Sciences has launched Luminos® Comprehensive, a next-generation IVDR-compliant clinical...
JERUSALEM, Israel, May 20, 2026 Scinai Immunotherapeutics Ltd. has announced the appointment of Eilon Elmalem as the new Site...
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...
WALNUT CREEK, CA, USA & SUZHOU, CHINA, April 27, 2026 Dark Horse Consulting Group (DHCG) and Porton Advanced have...
MUMBAI, India and TOKYO, Japan, April 16, 2026 Piramal Pharma Solutions (PPS) and Ajinomoto Bio-Pharma Services have announced a...
TORONTO, Canada; HAIFA, Israel; and POMPANO BEACH, Florida, April 7, 2026 NurExone Biologic Inc. announced that its U.S. subsidiary...
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
SUZHOU, China, March 2, 2026 XellSmart Pharmaceutical Co., Ltd. announced that it has received its fourth consecutive Investigational New...
